MIAT and diabetes mellitus: Several other lncRNAs, such as MALAT1 (122), myocardial infarction-associated transcript (MIAT) (123) and lnc-MGC, have been found to be dysregulated in diabetes-induced renal injury and are potential therapeutic targets for treating diabetes-induced nephropathy.